F. Markus Leweke

13.3k total citations · 1 hit paper
159 papers, 8.6k citations indexed

About

F. Markus Leweke is a scholar working on Pharmacology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, F. Markus Leweke has authored 159 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pharmacology, 38 papers in Psychiatry and Mental health and 37 papers in Molecular Biology. Recurrent topics in F. Markus Leweke's work include Cannabis and Cannabinoid Research (53 papers), Tryptophan and brain disorders (31 papers) and Schizophrenia research and treatment (25 papers). F. Markus Leweke is often cited by papers focused on Cannabis and Cannabinoid Research (53 papers), Tryptophan and brain disorders (31 papers) and Schizophrenia research and treatment (25 papers). F. Markus Leweke collaborates with scholars based in Germany, United Kingdom and Australia. F. Markus Leweke's co-authors include Dagmar Koethe, C.W. Gerth, Daniele Piomelli, Joachim Klosterkötter, H. M. Emrich, Andrea Giuffrida, Martin Hellmich, Cathrin Rohleder, Daniela Schreiber and Carolin Hoyer and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

F. Markus Leweke

156 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

2012 785 citations F. Markus Leweke, Daniele Piomelli et al. Translational Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Markus Leweke Germany	51	3.7k	2.6k	1.8k	1.8k	1.7k	159	8.6k
Gregers Wegener Denmark	51	1.6k 0.4×	2.6k 1.0×	2.3k 1.3×	910 0.5×	1.9k 1.1×	252	8.1k
Nakao Iwata Japan	52	1.5k 0.4×	3.0k 1.2×	1.3k 0.7×	3.0k 1.7×	3.3k 1.9×	482	11.4k
Gabriella Gobbi Canada	48	2.6k 0.7×	3.3k 1.3×	911 0.5×	949 0.5×	1.4k 0.8×	138	7.7k
Michael J. Owens United States	52	1.3k 0.4×	3.3k 1.3×	2.1k 1.2×	1.2k 0.7×	1.9k 1.1×	164	11.2k
James Stone United Kingdom	46	1.9k 0.5×	2.8k 1.1×	1.7k 0.9×	2.1k 1.2×	1.6k 0.9×	164	8.6k
Thomas C. Baghai Germany	45	1.2k 0.3×	1.7k 0.6×	1.5k 0.8×	1.3k 0.7×	1.3k 0.8×	170	6.7k
Victoria Arango United States	61	1.8k 0.5×	5.4k 2.1×	2.3k 1.3×	1.7k 1.0×	3.4k 2.0×	153	12.9k
Bernard Lerer Israel	58	1.9k 0.5×	2.9k 1.1×	1.4k 0.8×	4.3k 2.4×	2.8k 1.6×	339	12.6k
Dagmar Koethe Germany	34	2.2k 0.6×	1.4k 0.5×	812 0.5×	969 0.5×	745 0.4×	64	4.6k
Aleksander A. Mathé Sweden	60	1.4k 0.4×	4.3k 1.7×	1.9k 1.1×	1.6k 0.9×	2.4k 1.4×	235	11.3k

Countries citing papers authored by F. Markus Leweke

Since Specialization

Citations

This map shows the geographic impact of F. Markus Leweke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Markus Leweke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Markus Leweke more than expected).

Fields of papers citing papers by F. Markus Leweke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Markus Leweke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Markus Leweke. The network helps show where F. Markus Leweke may publish in the future.

Co-authorship network of co-authors of F. Markus Leweke

This figure shows the co-authorship network connecting the top 25 collaborators of F. Markus Leweke. A scholar is included among the top collaborators of F. Markus Leweke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Markus Leweke. F. Markus Leweke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Elizabeth, Richard B. Banati, David A. Brown, et al.. (2024). Neuroimmune-mediated neuropsychiatric syndromes: perspectives for standardised diagnostics and personalised care. 1.

Couttas, Timothy A., Franziska Pahlisch, Juliane K. Mueller, et al.. (2024). Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers. SHILAP Revista de lepidopterología. 27(1). e301027–e301027.

Rohleder, Cathrin, et al.. (2024). Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol. Psychiatry Research. 339. 116005–116005. 3 indexed citations

Hulka, Lea M., Matthias Vonmoos, Katrin H. Preller, et al.. (2023). Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density. Translational Psychiatry. 13(1). 325–325. 7 indexed citations

Koethe, Dagmar, Cathrin Rohleder, Lutz Kracht, & F. Markus Leweke. (2023). Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state. Frontiers in Psychiatry. 14. 1088459–1088459. 4 indexed citations

Couttas, Timothy A., Franziska Pahlisch, Dagmar Koethe, et al.. (2022). Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and N -Acylethanolamines by Liquid Chromatography–Tandem Mass Spectrometry. Cannabis and Cannabinoid Research. 8(4). 657–669. 11 indexed citations

Bien, Christian G., Cathrin Rohleder, Juliane K. Mueller, et al.. (2021). Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers. Frontiers in Psychiatry. 12. 654602–654602. 21 indexed citations

Rohleder, Cathrin, Yun Ju Christine Song, Jacob J. Crouse, et al.. (2020). Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health services. BMJ Open. 10(6). e035379–e035379. 7 indexed citations

Rohleder, Cathrin, Franziska Pahlisch, Rudolf Graf, Heike Endepols, & F. Markus Leweke. (2019). Different pharmaceutical preparations of Δ⁹‐tetrahydrocannabinol differentially affect its behavioral effects in rats. Addiction Biology. 25(3). e12745–e12745. 7 indexed citations

10.

Bouter, Yvonne, Magdalena M. Brzózka, Rafał Ryguła, et al.. (2019). Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57B l /6J Mice. Cannabis and Cannabinoid Research. 5(1). 51–61. 21 indexed citations

11.

Grent-‘t-Jong, Tineke, Joachim Groß, Jozien Goense, et al.. (2018). Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages. eLife. 7. 121 indexed citations

12.

Rohleder, Cathrin, Juliane Müller, Dušan Hirjak, Andreas Meyer‐Lindenberg, & F. Markus Leweke. (2018). Cannabidiol zur Verbesserung der Genesung in frühen Stadien einer Schizophrenie. Nervenheilkunde. 37(5). 319–323. 3 indexed citations

13.

Koethe, Dagmar, Franziska Pahlisch, Martin Hellmich, et al.. (2018). Familial abnormalities of endocannabinoid signaling in schizophrenia. The World Journal of Biological Psychiatry. 20(2). 117–125. 33 indexed citations

14.

Leweke, F. Markus, Juliane K. Mueller, Bettina Lange, et al.. (2018). Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention. CNS Drugs. 32(7). 605–619. 37 indexed citations

15.

Kranaster, Laura, Carolin Hoyer, Suna Su Aksay, et al.. (2017). Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study. European Archives of Psychiatry and Clinical Neuroscience. 267(8). 781–786. 36 indexed citations

16.

Bumb, Jan Malte, Frank Enning, Juliane K. Mueller, et al.. (2016). Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder. Comprehensive Psychiatry. 68. 34–39. 46 indexed citations

17.

Schneider, Miriam, Fernando Kasanetz, Diane L. Lynch, et al.. (2015). Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior. Journal of Neuroscience. 35(41). 13975–13988. 41 indexed citations

18.

Rohleder, Cathrin, Dirk Wiedermann, Bernd Neumaier, et al.. (2014). Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats. Frontiers in Behavioral Neuroscience. 8. 178–178. 22 indexed citations

19.

Koethe, Dagmar, Ida C. Llenos, Carolin Hoyer, et al.. (2007). Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. Journal of Neural Transmission. 114(8). 1055–1063. 138 indexed citations

20.

Emrich, H. M., F. Markus Leweke, & Udo Schneider. (1997). Towards a Cannabinoid Hypothesis of Schizophrenia: Cognitive Impairments Due to Dysregulation of the Endogenous Cannabinoid System. Pharmacology Biochemistry and Behavior. 56(4). 803–807. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact